AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Brentuximab vedotin in the treatment of relapsed/refractory CD30+peripheral T-cell lymphoma: A FIL phase 2 study

Vittorio Stefoni,Cinzia Pellegrini,Lisa Argnani,Paolo Corradini,Anna Dodero,Lorella Orsucci,Stefano Volpetti,Pier Luigi Zinzani

HEMATOLOGICAL ONCOLOGY（2022）

引用 1|浏览1
暂无评分
摘要
This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
更多
查看译文
关键词
brentuximab vedotin, novel agents, peripheral T-cell lymphomas, refractory, relapsed
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要